Author

Michael Roger Eccles

Maurice Wilkins CentreORCID 0000-0002-6824-8761Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genetic & Genomic Medicine· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:DNA methylation· 2 Approach:statistical model· 2 Research Focus:variant calling· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1

Frequent Co-Authors

Abhishek KumariD· 1 shared Andrew B. DasiD· 1 shared Aniruddha ChatterjeeiD· 1 shared Annette LashamiD· 1 shared Arthur Urbano· 1 shared Ben J. LawrenceiD· 1 shared Carlos C. Smith-DíaziD· 1 shared Cherie BlenkironiD· 1 shared

Activity by Year

2021-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 13 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Abhishek KumarORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologyFree Radical Biology and MedicinePeer-reviewedJan 8, 2025

Peroxidasin is associated with a mesenchymal-like transcriptional phenotype and promotes invasion in metastatic melanoma

Carlos C. Smith-Díaz, Abhishek Kumar, Andrew B. Das…·Martina Paumann-Page

This study shows that peroxidasin (PXDN) promotes invasion in metastatic melanoma by supporting a mesenchymal-like transcriptional phenotype, as demonstrated through transcriptomic and proteomic analyses.

6 citations

humanbulk RNA-seq

𝕏 PostBluesky

Genetic & Genomic MedicineMolecular Diagnosis & TherapyPeer-reviewedApr 26, 2023

Dynamic ctDNA mutational complexity in melanoma patients receiving immunotherapy

Sandra J. Fitzgerald, Cherie Blenkiron, Rosalie Stephens…·Cristin Gregor Print

This study tracks ctDNA mutational complexity in melanoma patients on immunotherapy, finding dynamic mutations and clinical correlations.

8 citations

humanDNA methylation

𝕏 PostBluesky

Molecular BiologybioRxivPreprintOct 12, 2021

Locus-Specific DNA Methylation Editing in Mammalian Cells using a CRISPR-Based System

Jim Smith, Rakesh Banerjee, Reema Waly…·Aniruddha Chatterjee

The paper describes a CRISPR-based system for locus-specific DNA methylation editing in human melanoma cells and demonstrates its efficacy in modifying the EBF3 promoter.

4 citations

humanDNA methylation

𝕏 PostBluesky